Single-Cell Imaging Shows That the Transcriptional State of the HIV-1 Provirus and Its Reactivation Potential Depend on the Integration Site
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
A longstanding question exists on the impact of the HIV-1 integration site on viral gene expression. This unsolved question has significant implications for the search toward an HIV-1 cure, as eradication strategies set up to reactivate and eliminate HIV-1 depend on the site where the provirus is integrated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, disruption of the IN-LEDGF/p75 interaction—either through LEDGF/p75 depletion or via small-molecule inhibitors known as LEDGINs—results in a shift of integration sites toward more inner nuclear compartments (49).”
From Research progress on HIV-1 structural proteins and antiviral therapies (2026) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The viral integrase (IN) interacts with the host protein LEDGF/p75, which facilitates the targeted insertion of viral DNA into transcriptionally active regions of the genome (49).”
From Research progress on HIV-1 structural proteins and antiviral therapies (2026) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods of Digital Video Microscopy for Colloidal Studies
Crocker, J. C., & Grier, D. G. (1996) · Journal of Colloid and Interface Science · doi:10.1006/jcis.1996.0217 · Cited by 3,765
(2012) · doi:10.1016/j.jmoldx.2011.08.002 · Cited by 2,567
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Sáez-Cirión, A., Bacchus, C., Hocqueloux, L., Avettand-Fenoel, V., Girault, I., Lecuroux, C., Potard, V., Versmisse, P., Melard, A., Prazuck, T., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003211 · Cited by 1,011
HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells
Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., & Debyser, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209278200 · Cited by 704 · cited 1×
“Furthermore, LEDGF/p75 encompasses two AT hook motifs for chromatin interaction (16, 17) and a C-terminal domain comprising the integrase binding domain (IBD) to which both HIV-1 integrase and cellular partners bind (18, 19).”
BackgroundSelf-citationA role for LEDGF/p75 in targeting HIV DNA integration
Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J. R., & Bushman, F. (2005) · Nature Medicine · doi:10.1038/nm1329 · Cited by 658 · cited 1×
“Depletion of LEDGF/p75 reduces integration (20) yet additionally shifts residual integration out of transcription units (7, 8, 21, 22).”
BackgroundAbsence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant
Persaud, D., Gay, H., Ziemniak, C., Chen, Y. H., Piatak, M., Chun, T.-W., Strain, M., Richman, D., & Luzuriaga, K. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302976 · Cited by 581
An essential role for LEDGF/p75 in HIV integration
Llano, M., Saenz, D. T., Meehan, A., Wongthida, P., Peretz, M., Walker, W. H., Teo, W., & Poeschla, E. M. (2006) · Science · doi:10.1126/science.1132319 · Cited by 537
Christ, F., Voet, A., Marchand, A., Nicolet, S., Desimmie, B. A., Marchand, D., Bardiot, D., Van der Veken, N. J., Van Remoortel, B., Strelkov, S. V., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.370 · Cited by 479
Self-citationJordan, A., Defechereux, P., & Verdin, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1726 · Cited by 467
Shun, M.-C., Raghavendra, N. K., Vandegraaff, N., Daigle, J. E., Hughes, S., Kellam, P., Cherepanov, P., & Engelman, A. (2007) · Genes & Development · doi:10.1101/gad.1565107 · Cited by 467 · cited 1×
“Depletion of LEDGF/p75 reduces integration (20) yet additionally shifts residual integration out of transcription units (7, 8, 21, 22).”
BackgroundSpatial Distribution of Di- and Tri-methyl Lysine 36 of Histone H3 at Active Genes
Bannister, A. J., Schneider, R., Myers, F. A., Thorne, A. W., Crane-Robinson, C., & Kouzarides, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500796200 · Cited by 459
Conference on Retroviruses and Opportunistic Infections 2015
(2015) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30481-7 · Cited by 421
Getting the “Kill” into “Shock and Kill”: Strategies to Eliminate Latent HIV
Kim, Y., Anderson, J. L., & Lewin, S. R. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2017.12.004 · Cited by 414
Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75
Cherepanov, P., Ambrosio, A. L. B., Rahman, S., Ellenberger, T., & Engelman, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506924102 · Cited by 408
Distinct viral reservoirs in individuals with spontaneous control of HIV-1
Jiang, C., Lian, X., Gao, C., Sun, X., Einkauf, K. B., Chevalier, J. M., Chen, S. M. Y., Hua, S., Rhee, B., Chang, K., et al. (2020) · Nature · doi:10.1038/s41586-020-2651-8 · Cited by 385
Nuclear architecture dictates HIV-1 integration site selection
Marini, B., Kertesz-Farkas, A., Ali, H., Lucic, B., Lisek, K., Manganaro, L., Pongor, S., Luzzati, R., Recchia, A., Mavilio, F., et al. (2015) · Nature · doi:10.1038/nature14226 · Cited by 335
Einkauf, K. B., Lee, G. Q., Gao, C., Sharaf, R., Sun, X., Hua, S., Chen, S. M. Y., Jiang, C., Lian, X., Chowdhury, F. Z., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124291 · Cited by 295
Cherepanov, P., Devroe, E., Silver, P. A., & Engelman, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406307200 · Cited by 287
Genome-Wide Analysis of Chromosomal Features Repressing Human Immunodeficiency Virus Transcription
Lewinski, M. K., Bisgrove, D., Shinn, P., Chen, H., Hoffmann, C., Hannenhalli, S., Verdin, E., Berry, C. C., Ecker, J. R., & Bushman, F. D. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.6610-6619.2005 · Cited by 270
Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1
Hill, A. L., Rosenbloom, D. I. S., Fu, F., Nowak, M. A., & Siliciano, R. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406663111 · Cited by 265
Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses
Einkauf, K. B., Osborn, M. R., Gao, C., Sun, W., Sun, X., Lian, X., Parsons, E. M., Gladkov, G. T., Seiger, K. W., Blackmer, J. E., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.011 · Cited by 260
Sowd, G. A., Serrao, E., Wang, H., Wang, W., Fadel, H. J., Poeschla, E. M., & Engelman, A. N. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524213113 · Cited by 249
Role of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting
Marshall, H. M., Ronen, K., Berry, C., Llano, M., Sutherland, H., Saenz, D., Bickmore, W., Poeschla, E., & Bushman, F. D. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001340 · Cited by 241
Han, Y., Lin, Y. B., An, W., Xu, J., Yang, H.-C., O'Connell, K., Dordai, D., Boeke, J. D., Siliciano, J. D., & Siliciano, R. F. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.06.008 · Cited by 215
Capsid-CPSF6 Interaction Licenses Nuclear HIV-1 Trafficking to Sites of Viral DNA Integration
Achuthan, V., Perreira, J. M., Sowd, G. A., Puray-Chavez, M., McDougall, W. M., Paulucci-Holthauzen, A., Wu, X., Fadel, H. J., Poeschla, E. M., Multani, A. S., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.08.002 · Cited by 205 · cited 1×
“but not all (14), studies claim that the location of retargeted proviruses either induced”
BackgroundLlano, M., Vanegas, M., Hutchins, N., Thompson, D., Delgado, S., & Poeschla, E. M. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.04.073 · Cited by 199
Abrahams, M.-R., Joseph, S. B., Garrett, N., Tyers, L., Moeser, M., Archin, N., Council, O. D., Matten, D., Zhou, S., Doolabh, D., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw5589 · Cited by 196
Battivelli, E., Dahabieh, M. S., Abdel-Mohsen, M., Svensson, J. P., Tojal Da Silva, I., Cohn, L. B., Gramatica, A., Deeks, S., Greene, W. C., Pillai, S. K., et al. (2018) · eLife · doi:10.7554/elife.34655 · Cited by 184
Multimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors
Kessl, J. J., Jena, N., Koh, Y., Taskent-Sezgin, H., Slaughter, A., Feng, L., de Silva, S., Wu, L., Le Grice, S. F. J., Engelman, A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.354373 · Cited by 182
Turlure, F. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl052 · Cited by 181 · cited 1×
“Furthermore, LEDGF/p75 encompasses two AT hook motifs for chromatin interaction (16, 17) and a C-terminal domain comprising the integrase binding domain (IBD) to which both HIV-1 integrase and cellular partners bind (18, 19).”
BackgroundChrist, F., Shaw, S., Demeulemeester, J., Desimmie, B. A., Marchand, A., Butler, S., Smets, W., Chaltin, P., Westby, M., Debyser, Z., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00717-12 · Cited by 176
Self-citationLEDGF Hybrids Efficiently Retarget Lentiviral Integration Into Heterochromatin
Gijsbers, R., Ronen, K., Vets, S., Malani, N., Rijck, J. D., McNeely, M., Bushman, F. D., & Debyser, Z. (2010) · Molecular Therapy · doi:10.1038/mt.2010.36 · Cited by 172
Self-citationHIV “shock and kill” therapy: In need of revision
Abner, E., & Jordan, A. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.03.008 · Cited by 170
New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action
Tsiang, M., Jones, G. S., Niedziela-Majka, A., Kan, E., Lansdon, E. B., Huang, W., Hung, M., Samuel, D., Novikov, N., Xu, Y., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.347534 · Cited by 167
Chin, C. R., Perreira, J. M., Savidis, G., Portmann, J. M., Aker, A. M., Feeley, E. M., Smith, M. C., & Brass, A. L. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.036 · Cited by 166
Position effects influence HIV latency reversal
Chen, H.-C., Martinez, J. P., Zorita, E., Meyerhans, A., & Filion, G. J. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3328 · Cited by 165
The role of unintegrated DNA in HIV infection
Sloan, R. D., & Wainberg, M. A. (2011) · Retrovirology · doi:10.1186/1742-4690-8-52 · Cited by 158
HIV-1 Vpr—a still “enigmatic multitasker”
Guenzel, C. A., Hérate, C., & Bénichou, S. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00127 · Cited by 156
Establishment and stability of the latent HIV-1 DNA reservoir
Brodin, J., Zanini, F., Thebo, L., Lanz, C., Bratt, G., Neher, R. A., & Albert, J. (2016) · eLife · doi:10.7554/elife.18889 · Cited by 156
LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions
Desimmie, B. A., Schrijvers, R., Demeulemeester, J., Borrenberghs, D., Weydert, C., Thys, W., Vets, S., Van Remoortel, B., Hofkens, J., De Rijck, J., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-57 · Cited by 139
Self-citationThe LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy
Christ, F., & Debyser, Z. (2012) · Virology · doi:10.1016/j.virol.2012.09.033 · Cited by 131
Self-citationLe Rouzic, E., Bonnard, D., Chasset, S., Bruneau, J.-M., Chevreuil, F., Le Strat, F., Nguyen, J., Beauvoir, R., Amadori, C., Brias, J., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-144 · Cited by 127
Balakrishnan, M., Yant, S. R., Tsai, L., O’Sullivan, C., Bam, R. A., Tsai, A., Niedziela-Majka, A., Stray, K. M., Sakowicz, R., & Cihlar, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074163 · Cited by 126 · cited 2×
“Since their initial discovery, compounds of different chemical nature but belonging to the same functional class have been described (26), including noncatalytic site integrase inhibitors (NCINIs) (27), allosteric integrase inhibitors (ALLINIs) (28), multimerization selective integrase inhibitors (MINIs) (29), and int…”
BackgroundA New Class of Multimerization Selective Inhibitors of HIV-1 Integrase
Sharma, A., Slaughter, A., Jena, N., Feng, L., Kessl, J. J., Fadel, H. J., Malani, N., Male, F., Wu, L., Poeschla, E., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004171 · Cited by 124 · cited 1×
“Since their initial discovery, compounds of different chemical nature but belonging to the same functional class have been described (26), including noncatalytic site integrase inhibitors (NCINIs) (27), allosteric integrase inhibitors (ALLINIs) (28), multimerization selective integrase inhibitors (MINIs) (29), and int…”
BackgroundVranckx, L. S., Demeulemeester, J., Saleh, S., Boll, A., Vansant, G., Schrijvers, R., Weydert, C., Battivelli, E., Verdin, E., Cereseto, A., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.04.039 · Cited by 113 · cited 13×
“LEDGINs can also affect HIV-1 latency and reactivation (21, 32, 33).”
BackgroundResultInfluentialSelf-citationBradley, T., Ferrari, G., Haynes, B. F., Margolis, D. M., & Browne, E. P. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.020 · Cited by 110
Golumbeanu, M., Cristinelli, S., Rato, S., Munoz, M., Cavassini, M., Beerenwinkel, N., & Ciuffi, A. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.102 · Cited by 108
Deep latency: A new insight into a functional HIV cure
Elsheikh, M. M., Tang, Y., Li, D., & Jiang, G. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.06.020 · Cited by 85
LEDGINs, non-catalytic site inhibitors of HIV-1 integrase: a patent review (2006 – 2014)
Demeulemeester, J., Chaltin, P., Marchand, A., De Maeyer, M., Debyser, Z., & Christ, F. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.898753 · Cited by 83
Self-citationDual-color HIV reporters trace a population of latently infected cells and enable their purification
Calvanese, V., Chavez, L., Laurent, T., Ding, S., & Verdin, E. (2013) · Virology · doi:10.1016/j.virol.2013.07.037 · Cited by 81
The chromatin landscape at the HIV-1 provirus integration site determines viral expression
Vansant, G., Chen, H., Zorita, E. V., Trejbalová, K., Miklík, D., Filion, G. J. P., & Debyser, Z. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa536 · Cited by 81
Self-citationEpigenetic Heterogeneity in HIV-1 Latency Establishment
Matsuda, Y., Kobayashi‐Ishihara, M., Fujikawa, D., Ishida, T., Watanabe, T., & Yamagishi, M. (2015) · Scientific Reports · doi:10.1038/srep07701 · Cited by 79
Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers.
Gonzalo-Gil, E., Ikediobi, U., & Sutton, R. E. (2017) · PubMed Central · Cited by 78
Rasheedi, S., Shun, M.-C., Serrao, E., Sowd, G. A., Qian, J., Hao, C., Dasgupta, T., Engelman, A. N., & Skowronski, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721647 · Cited by 65
Single-Cell Imaging of HIV-1 Provirus (SCIP)
Di Primio, C., Quercioli, V., Allouch, A., Gijsbers, R., Christ, F., Debyser, Z., Arosio, D., & Cereseto, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216254110 · Cited by 60
Self-citationRole of Viral Protein U (Vpu) in HIV-1 Infection and Pathogenesis
Khan, N., & Geiger, J. D. (2021) · Viruses · doi:10.3390/v13081466 · Cited by 58
HIV integration sites and implications for maintenance of the reservoir
Symons, J., Cameron, P. U., & Lewin, S. R. (2017) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000438 · Cited by 54
Multiplex single-cell visualization of nucleic acids and protein during HIV infection
Puray-Chavez, M., Tedbury, P. R., Huber, A. D., Ukah, O. B., Yapo, V., Liu, D., Ji, J., Wolf, J. J., Engelman, A. N., & Sarafianos, S. G. (2017) · Nature Communications · doi:10.1038/s41467-017-01693-z · Cited by 52
Maehigashi, T., Ahn, S., Kim, U.-I., Lindenberger, J. J., Oo, A., Koneru, P. C., Mahboubi, B., Engelman, A., Kvaratskhelia, M., Kim, K., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009671 · Cited by 40
GS-9822, a Preclinical LEDGIN Candidate, Displays a Block-and-Lock Phenotype in Cell Culture
Bruggemans, A., Vansant, G., Balakrishnan, M., Mitchell, M. L., Cai, R., Christ, F., & Debyser, Z. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02328-20 · Cited by 35
Self-citationImpact of LEDGIN treatment during virus production on residual HIV-1 transcription
Vansant, G., Vranckx, L. S., Zurnic, I., Looveren, D. V., de Velde, P. V., Nobles, C. L., Gijsbers, R., Christ, F., & Debyser, Z. (2019) · Retrovirology · doi:10.1186/s12977-019-0472-3 · Cited by 33
Self-citationTreatment with suboptimal doses of raltegravir leads to aberrant HIV-1 integrations
Varadarajan, J., McWilliams, M. J., & Hughes, S. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305066110 · Cited by 29
Modulation of the intrinsic chromatin binding property of HIV-1 integrase by LEDGF/p75
Lapaillerie, D., Lelandais, B., Mauro, E., Lagadec, F., Tumiotto, C., Miskey, C., Ferran, G., Kuschner, N., Calmels, C., Métifiot, M., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab886 · Cited by 23
Single-Cell Technologies Applied to HIV-1 Research: Reaching Maturity
Sannier, G., Dubé, M., & Kaufmann, D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00297 · Cited by 21
Miklík, D., Šenigl, F., & Hejnar, J. (2018) · Viruses · doi:10.3390/v10030116 · Cited by 17
HIV enters deep sleep in people who naturally control the virus
Chomont, N. (2020) · Nature · doi:10.1038/d41586-020-02438-7 · Cited by 11
Cited by
Immune targeting of HIV-1 reservoir cells: a path to elimination strategies and cure
Armani-Tourret, M., Bone, B., Tan, T. S., Sun, W., Bellefroid, M., Struyve, T., Louella, M., Yu, X. G., & Lichterfeld, M. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01010-8 · Cited by 67
New latency-promoting agents for a block-and-lock functional cure strategy
Pellaers, E., Denis, A., & Debyser, Z. (2024) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000844 · Cited by 13
Self-citationResearch progress on HIV-1 structural proteins and antiviral therapies
Wang, H., Yuan, J., & Wang, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1805597 · Cited by 2
“Furthermore, disruption of the IN-LEDGF/p75 interaction — either through LEDGF/p75 depletion or via small-molecule inhibitors known as LEDGINs — results in a shift of integration sites toward more inner nuclear compartments (49).”
Metadata
- Authors
- Janssens, J., De Wit, F., Parveen, N., & Debyser, Z.
- Affiliations
- KU Leuven (BE)
- Molecular Virology and Gene Therapy, KU Leuven, Leuven, Belgium
- Indian Institute of Technology Kanpur (IN)
- Corresponding author
- Debyser, Zeger
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2022-08-30
- Volume
- 13
- Issue
- 4
- Pages
- e0000722-e0000722
- ISSN
- 2150-7511 (ISSN-L)
- PMC
- PMC9426465
- OpenAlex
- W4282980960
- Cited by
- 28
- References
- 67
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 11 · 2023: 4 · 2022: 1
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- mBio (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lirias (KU Leuven) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fonds Wetenschappelijk Onderzoek (G0A5316N, SBO-Saphir)
- KU Leuven research council (C14/17/095-3M170311)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- HIV-1 provirus, integration sites, HIV-1 transcription, viral reactivation, LEDGF/p75, HIV-1 integrase, 3D genome organization, HIV-1 cure, chromatin targeting
- MeSH terms
- Chromatin, HIV Seropositivity, Humans, Proviruses, Virus Replication, HIV-1, Virus Integration, HIV Integrase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.